Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 39Squamous Cell Carcinoma of Head and Neck 17Head and Neck Neoplasms 7Recurrence 5Laryngeal Neoplasms 4Hypopharyngeal Neoplasms 4Nasopharyngeal Neoplasms 3Sarcoma 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Carcinoma, Squamous Cell 2Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Sinonasal undifferentiated carcinoma 1Salivary Gland Malignant Neoplasms 1Pathologic Complete Response 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Paranasal Sinus Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer 1Locally Advanced Hypopharyngeal Carcinoma 1Head and Neck Squamous Cell Cancer 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 7Cisplatin 7Carboplatin 5Surveys and Questionnaires 3Paclitaxel 3Taxes 2Radiation 2Docetaxel 2Cetuximab 2Albumin-Bound Paclitaxel 2utomilumab 1toripalimab 1infigratinib 1fludarabine phosphate 1fludarabine 1durvalumab 1aldesleukin 1Specimen Handling 1Radiotherapy 1Platinum 1Nimorazole 1Mass Screening 1Liquid Biopsy 1Immunoglobulin G 1Hydroxyurea 1Gene Expression Profiling 1Focus Groups 1Fluorouracil 1Drug Therapy 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papillomavirus Infections × toripalimab × Head & Neck × Clear all
NCT07209189 2026-04-23

(NeoScorch HN)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
75 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡